|
|
|
|
|
|
Notes
|
Dec. 31, 2019
|
|
Dec. 31, 2018
|
|
EGP Thousands
|
|
EGP Thousands
|
|
|
|
|
|
Net profit for the period
|
|
11,803,555
|
|
9,555,755
|
Other comprehensive income items that will not be reclassified to the Profit or Loss:
|
|
|
|
|
Net change in fair value of debt instruments measured at fair value through other comprehensive income
|
|
212,967
|
|
57,026
|
Other comprehensive income items that is or may be reclassified to the profit or loss:
|
|
|
|
|
Net change in fair value of debt instruments measured at fair value through other comprehensive income
|
|
5,944,586
|
|
(2,164,847)
|
Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income
|
|
(184,921)
|
|
-
|
Total other comprehensive income for the year
|
|
17,776,187
|
|
7,447,934
|
|
|
|
|
|
|
|
|
|
|
Separate cash flow for the period ended December 31, 2019
|
|
Notes
|
Dec. 31, 2019
|
|
Dec. 31, 2018
|
|
|
EGP Thousands
|
|
EGP Thousands
|
|
|
|
|
|
Cash flow from operating activities
|
|
|
|
|
Profit before income tax
|
|
16,537,441
|
|
13,052,594
|
Adjustments to reconcile net profit to net cash provided by operating activities
|
|
|
|
|
Fixed assets depreciation
|
24
|
576,544
|
|
390,830
|
Impairment charge for credit losses (Loans and advances to customers)
|
12
|
1,610,878
|
|
3,076,023
|
Other provisions charges
|
29
|
461,869
|
|
101,501
|
Impairment charge for credit losses (due from banks)
|
12
|
9,503
|
|
-
|
Impairment charge for credit losses (financial investments)
|
12
|
(184,921)
|
|
-
|
Impairment charge for other assets
|
23
|
(93,313)
|
|
316,763
|
Exchange revaluation differences for financial assets at fair value through OCI
|
20
|
1,593,030
|
|
(102,991)
|
Intangible assets amortization
|
|
238,715
|
|
130,208
|
Impairment charge financial assets at fair value through OCI
|
21
|
-
|
|
39,561
|
Exchange differences in financial investments in subsidiary
|
22
|
4,680
|
|
(465)
|
Utilization of other provisions
|
29
|
(28,135)
|
|
(2,114)
|
Other provisions no longer used
|
29
|
(6,910)
|
|
(17,670)
|
Exchange differences of other provisions
|
29
|
(110,062)
|
|
(2,269)
|
(Profits) losses from selling property, plant and equipment
|
11
|
(1,439)
|
|
(1,045)
|
(Profits) losses from selling financial investments
|
21
|
(497,894)
|
|
(441,628)
|
Shares based payments
|
|
464,539
|
|
408,346
|
Operating profits before changes in operating assets and liabilities
|
|
20,574,525
|
|
16,947,644
|
|
|
|
|
|
Net decrease (increase) in assets and liabilities
|
|
|
|
|
Due from banks
|
15
|
(8,870,547)
|
|
(13,661,577)
|
Treasury bills and other governmental notes
|
41
|
-
|
|
4,640,524
|
Financial assets at fair value through P&L
|
21
|
2,318,924
|
|
4,557,492
|
Derivative financial instruments
|
20
|
(2,910)
|
|
(66,141)
|
Loans and advances to banks and customers
|
18 - 19
|
(14,533,328)
|
|
(21,255,952)
|
Other assets
|
42
|
162,502
|
|
(2,263,465)
|
Due to banks
|
25
|
4,550,788
|
|
5,381,901
|
Due to customers
|
26
|
19,143,183
|
|
34,573,102
|
Income tax obligations paid
|
|
(3,625,579)
|
|
(2,778,973)
|
Other liabilities
|
28
|
1,894,934
|
|
1,025,022
|
Net cash provided from operating activities
|
|
21,612,492
|
|
27,099,577
|
|
|
|
|
|
Cash flow from investing activities
|
|
|
|
|
Payment for purchases of subsidiary and associates
|
|
-
|
|
(10,575)
|
Payment for purchases of property, plant, equipment and branches constructions
|
|
(1,301,415)
|
|
(874,708)
|
Proceeds from selling property, plant and equipment
|
11
|
1,439
|
|
1,045
|
Proceeds from redemption of financial assets at amortized cost
|
21
|
43,937,957
|
|
5,532,271
|
Payment for purchases of financial assets at amortized cost
|
21
|
(76,516,842)
|
|
(33,995,313)
|
Payment for purchases of financial assets at fair value through OCI
|
21
|
(50,954,311)
|
|
(12,670,761)
|
Proceeds from selling financial assets at fair value through OCI
|
|
54,855,966
|
|
2,059,341
|
Net cash used in investing activities
|
|
(29,977,206)
|
|
(39,958,700)
|
|
|
|
|
|
Cash flow from financing activities
|
|
|
Increase (decrease) in long term loans
|
27
|
(448,783)
|
46,793
|
Dividend paid
|
|
(2,700,544)
|
(2,143,177)
|
Capital increase
|
|
105,413
|
50,315
|
Net cash used in (provided from) financing activities
|
|
(3,043,914)
|
(2,046,069)
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalent during the year
|
|
(11,408,628)
|
(14,905,192)
|
Beginning balance of cash and cash equivalent
|
|
34,303,645
|
49,208,837
|
Cash and cash equivalent at the end of the year
|
|
22,895,017
|
34,303,645
|
|
|
|
|
|
|
|
Cash and cash equivalent comprise:
|
|
|
Cash and balances with central bank
|
15
|
28,273,962
|
20,058,974
|
Due from banks
|
16
|
28,370,183
|
46,518,892
|
Treasury bills and other governmental notes
|
17
|
27,634,062
|
41,999,252
|
Obligatory reserve balance with CBE
|
15
|
(22,397,310)
|
(13,526,763)
|
Due from banks with maturities more than three months
|
|
(10,593,903)
|
(10,733,386)
|
Treasury bills with maturity more than three months
|
|
(28,391,977)
|
(50,013,324)
|
Total cash and cash equivalent
|
|
22,895,017
|
34,303,645
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|